查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年数位呼吸设备市场预测：按产品、疾病、配销通路、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383407

到 2030 年数位呼吸设备市场预测：按产品、疾病、配销通路、最终用户和地区进行的全球分析

Digital Respiratory Devices Market Forecasts to 2030 - Global Analysis By Product, Disease, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球数位呼吸设备市场规模为 465 亿美元，预计预测期内年复合成长率为 27.5%，到 2030 年将达到 2,549 亿美元。

数位呼吸设备是一个医疗保健领域，涉及开发和利用数位技术来监测和管理呼吸系统疾病。这些设备旨在帮助诊断、治疗和持续管理气喘、慢性阻塞性肺病(COPD) 和其他呼吸系统疾病等疾病。应用包括即时监测肺功能、追踪用药医嘱遵从性和远端系统管理。

根据世界卫生组织（WHO）预测（2020年），到2030年，慢性阻塞性肺病将超过缺血性心臟疾病和爱滋病毒/爱滋病，成为第四大死因。

呼吸道疾病盛行率增加

气喘、慢性阻塞性肺病( COPD) 和睡眠呼吸中止疾病呈上升趋势，推动了对监测、管理和改善呼吸系统健康的创新解决方案的需求。数位呼吸设备提供即时监测、资料收集和个体化治疗计划，使患者和医疗保健提供者能够有效解决这些问题。随着呼吸系统疾病的负担变得更加突出，这些设备在加强患者照护、早期疗育和自我管理方面发挥关键作用，最终改善受这些疾病影响的人们的生活质量，并促进市场成长。

与现有医疗保健系统的兼容性和集成

医疗保健系统通常使用各种电子健康记录(EHR) 和资料管理平台，这些平台可能不容易容纳新的数位呼吸设备或与新的数位呼吸设备通讯。缺乏互通性阻碍了患者资料的无缝交换，并使医疗保健提供者难以将设备生成的资讯纳入患者记录和治疗计划中。为了克服这一限制，标准化的资料格式、改进的通讯协定以及数位呼吸设备与现有医疗保健系统的无缝整合将实现更有效的患者照护和资料主导，需要配合措施才能做到这一点。

远端医疗和远端患者监护技术的发展

这些技术在医疗保健领域已变得至关重要，可提供呼吸道疾病的即时远端监测。数位呼吸设备能够很好地利用这一趋势，为患者提供一种检测重要呼吸资料并将其传输给医疗保健提供者的方法，从而促进远端咨询和主动护理。这不仅增加了患者的便利性，还改善了病情加重的早期检测并支持个人化治疗计划。将数位呼吸设备整合到远距医疗平台中符合不断发展的医疗保健形势，提供以患者为中心的方法，并扩大改善呼吸护理的市场潜力。

资料隐私和安全问题

收集和传输敏感的患者健康资料会增加资料外洩和诈欺存取的风险，这可能对患者隐私产生严重影响。法规和强有力的网路安全措施对于保护这些资料至关重要。资料外洩和资料滥用的威胁可能会破坏患者的信任并阻碍数位呼吸设备的采用。为了克服这项威胁，需要采取严格的资料保护措施、加密协定和全面的资料安全策略，确保病患资讯的隐私和安全性，并维持数位呼吸医疗解决方案的完整性。

COVID-19 的影响：

COVID-19 的疫情对市场产生了重大影响。呼吸健康已成为全球关注的前沿问题，对包括数位呼吸设备在内的远端监控和远端医疗解决方案的需求激增。这些设备使医疗保健提供者能够远端监控和管理呼吸状况，同时最大限度地减少面对面接触并降低病毒传播的风险。这场大流行加速了这些技术的采用，使其成为医疗保健生态系统的重要组成部分。此外，大流行期间对呼吸健康的关注提高了医疗保健提供者和患者对数位呼吸设备的认识和接受度。

雾化器市场预计将在预测期内成为最大的市场

雾化器领域预计将出现良好的成长。这些设备广泛用于治疗各种呼吸系统疾病，包括气喘和慢性阻塞性肺病（COPD）。数位雾化器具有精确的给药传递、增强的便携性以及用于远端监测和治疗调整的资料连接等优点。使患者能够更有效地管理他们的呼吸健康，提高用药医嘱遵从性，并使医疗保健提供者能够远端监控治疗依从性。数位雾化器有助于改善患者的治疗效果并减轻呼吸系统疾病的负担，从而推动市场的采用。

医院部门预计在预测期内年复合成长率最高

预计医院产业在预测期内将以最快的年复合成长率成长。这些医疗机构依靠数位呼吸设备对患有气喘、慢性阻塞性肺病(COPD) 和睡眠呼吸中止呼吸系统症候群的患者进行准确诊断、监测和治疗。数位呼吸设备透过提供有关肺功能、药物医嘱遵从性和治疗效果的即时资料来增强患者护理。这使得医疗保健专业人员能够做出资讯的决定并快速调整治疗计划。在医院使用这些设备不仅可以改善患者的治疗效果，还有助于提高呼吸护理的整体效率和质量，使其成为医疗保健生态系统的重要组成部分。

比最大的地区

预计北美市场在预测期内将继续占据大部分市场占有率。该地区由美国和加拿大组成，高龄化、环境因素和文明病导致呼吸道疾病负担日益增加。数位呼吸设备已在北美广泛采用，为监测、诊断和管理这些疾病提供了先进的解决方案。此外，该地区对远端医疗和远端监控技术的投资正在加速数位呼吸设备融入医疗保健生态系统。北美因其对创新和卓越医疗保健的承诺而成为全球数位呼吸设备市场的主要驱动力。

复合年复合成长率最高的地区：

预计亚太地区在预测期内复合年复合成长率最高。在中国和印度等国家，人口不断增长，呼吸道疾病的盛行率也增加。该地区正在对医疗基础设施进行大量投资，并采用数位医疗技术，包括数位呼吸设备。这些设备使医疗保健提供者能够接触到更多的患者群体并更好地管理呼吸系统疾病，特别是在偏远地区。此外，亚太地区专注于远端医疗、远端患者监护和个人化医疗，被定位为一个充满活力且不断扩大的数位呼吸设备市场，为改善呼吸照护和患者治疗效果提供了巨大潜力。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球数位呼吸设备市场：按产品

  • 呼吸消耗品
    • 呼吸面罩
    • 氧气鼻管
    • 氧气管组
    • 呼吸过滤器
  • 喷雾器
    • 压缩喷射雾化器
    • 超音波雾化器
    • 其他雾化器
  • 氧气浓缩机
    • 家用氧气浓缩机
    • 便携式氧气浓缩机
  • 正压呼吸器(PAP)设备
  • 睡眠多项生理检查
  • 门诊 PSG 设备
  • 临床PSG装置
  • 脉搏血氧仪
  • 人工呼吸器
  • 肺活量计
  • 其他产品

第6章全球数位呼吸设备市场：依疾病分类

  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 其他疾病

第7章全球数位呼吸设备市场：按配销通路

  • 医院药房
  • 零售药房
  • 网路药房
  • 其他配销通路

第8章全球数位呼吸设备市场：依最终用户分类

  • 医院
  • 居家照护环境
  • 其他最终用户

第9章全球数位呼吸设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • 3M Health Care Limited
  • Adherium Limited
  • AireHealth, Inc.
  • Amiko Digital Health Limited
  • Cognita Labs
  • COHERO Health Inc.
  • FindAir Sp. z oo
  • Novartis AG
  • Pneuma Respiratory Inc.
  • Propeller Health
  • Teva Pharmaceuticals Industries Ltd.
Product Code: SMRC24256

According to Stratistics MRC, the Global Digital Respiratory Devices Market is accounted for $46.5 billion in 2023 and is expected to reach $254.9 billion by 2030 growing at a CAGR of 27.5% during the forecast period. The Digital Respiratory Devices is the healthcare sector involving the development and utilization of digital technologies to monitor and manage respiratory conditions. These devices are designed to assist in the diagnosis, treatment, and ongoing management of diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Their uses include real-time monitoring of lung function, medication adherence tracking, and remote patient management.

According to the World Health Organization prediction (2020), COPD will surpass ischemic heart disease and HIV/AIDS to become the fourth-leading causes of death, respectively, by 2030.

Market Dynamics:

Driver:

Increasing prevalence of respiratory diseases

Conditions like asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are on the rise, leading to a growing need for innovative solutions to monitor, manage, and improve respiratory health. Digital respiratory devices offer real-time monitoring, data collection, and personalized treatment plans, empowering patients and healthcare providers to effectively address these conditions. With the burden of respiratory diseases becoming more pronounced, these devices play a vital role in enhancing patient care, early intervention, and self-management, ultimately improving the quality of life for individuals affected by such conditions and driving market growth.

Restraint:

Compatibility and integration with existing healthcare systems

Health systems often use various electronic health records (EHR) and data management platforms, which may not readily accommodate or communicate with new digital respiratory devices. This lack of interoperability hinders the seamless exchange of patient data, making it difficult for healthcare providers to incorporate device-generated information into patient records and treatment plans. Overcoming this restraint requires standardized data formats, improved communication protocols, and collaborative efforts to ensure that digital respiratory devices can seamlessly integrate with existing healthcare systems, enabling more effective patient care and data-driven interventions.

Opportunity:

Growth of telehealth and remote patient monitoring technologies

These technologies have become integral in healthcare, offering real-time remote monitoring of respiratory conditions. Digital respiratory devices are well-positioned to leverage this trend by providing patients with the means to measure and transmit vital respiratory data to healthcare providers, facilitating remote consultations and proactive care. This not only enhances patient convenience but also improves early detection of exacerbations and supports personalized treatment plans. The integration of digital respiratory devices into telehealth platforms aligns with the evolving healthcare landscape, offering a patient-centric approach and expanding the market's potential for improved respiratory care.

Threat:

Data privacy and security concerns

With the collection and transmission of sensitive patient health data, there is an increased risk of data breaches and unauthorized access, which can have serious consequences for patient privacy. Regulatory compliance and robust cybersecurity measures are paramount to safeguarding this data. The threat of breaches or data misuse can erode patient trust and hinder the adoption of digital respiratory devices. Overcoming this threat requires stringent data protection measures, encryption protocols, and comprehensive data security strategies to ensure patient information remains confidential and secure, thereby preserving the integrity of digital respiratory healthcare solutions.

COVID-19 Impact:

The COVID-19 pandemic had a significant impact on the market. With respiratory health at the forefront of global concerns, the demand for remote monitoring and telehealth solutions, including digital respiratory devices, surged. These devices allowed healthcare providers to remotely monitor and manage respiratory conditions while minimizing in-person contact, reducing the risk of virus transmission. The pandemic accelerated the adoption of these technologies, making them an essential component of the healthcare ecosystem. Additionally, they focus on respiratory health during the pandemic created greater awareness and acceptance of digital respiratory devices among both healthcare providers and patients.

The nebulizers segment is expected to be the largest during the forecast period

The nebulizers segment is expected to have a lucrative growth. These devices are widely used for treating various respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). Digital nebulizers offer advantages such as precise dosage delivery, enhanced portability, and data connectivity for remote monitoring and treatment adjustment. They empower patients to manage their respiratory health more effectively, improve medication adherence, and enable healthcare providers to monitor treatment compliance remotely. Digital nebulizers are instrumental in enhancing patient outcomes and reducing the burden of respiratory diseases, driving their adoption in the market.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period. These healthcare facilities rely on digital respiratory devices for the precise diagnosis, monitoring, and treatment of patients with respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Digital respiratory devices enhance patient care by providing real-time data on lung function, medication adherence, and treatment effectiveness. They enable healthcare professionals to make informed decisions and adjust treatment plans promptly. The use of these devices in hospitals not only improves patient outcomes but also contributes to the overall efficiency and quality of respiratory care, making them integral components of the healthcare ecosystem.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region comprises the United States and Canada, where an aging population, environmental factors, and lifestyle-related conditions contribute to the growing burden of respiratory ailments. Digital respiratory devices are widely adopted in North America, offering advanced solutions for monitoring, diagnosing, and managing these conditions. Moreover, the region's investment in telehealth and remote monitoring technologies has accelerated the integration of digital respiratory devices into the healthcare ecosystem. North America's commitment to innovation and healthcare excellence positions it as a key driver in the global digital respiratory devices market.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. With a vast and growing population, there is an increasing prevalence of respiratory diseases in countries like China and India. The region is witnessing significant investments in healthcare infrastructure and the adoption of digital health technologies, including digital respiratory devices. These devices enable healthcare providers to reach a wider patient base, especially in remote areas, and enhance the management of respiratory conditions. Moreover, the Asia Pacific's focus on telehealth, remote patient monitoring, and personalized healthcare positions it as a dynamic and expanding market for digital respiratory devices, offering significant potential for improving respiratory care and patient outcomes.

Key players in the market

Some of the key players in Digital Respiratory Devices market include: 3M Health Care Limited, Adherium Limited, AireHealth, Inc., Amiko Digital Health Limited, Cognita Labs, COHERO Health Inc., FindAir Sp. z o.o, Novartis AG, Pneuma Respiratory Inc., Propeller Health and Teva Pharmaceuticals Industries Ltd.

Key Developments:

In February 2023, Adherium Limited, a market leader in respiratory eHealth, remote monitoring, and data management, announced that the FDA's 510(k) approval has allowed it to begin selling its first, next-generation Hailie Sensor, which includes physiological measures for tracking the use of asthma and COPD medications.

In September 2022, Propeller Health expanded their pharmacy refill app to cover CVS, Rite-Aid, Kroger, and Walmart pharmacies.

In July 2022, Propeller Health also launched My Drugstore, an in-app service in collaboration with Walgreens that allows clients to manage their medication refills for COPD and asthma and locate a nearby pharmacy.

Products Covered:

  • Respiratory Consumables
  • Nebulizers
  • Oxygen Concentrators
  • Positive Airway Pressure (PAP) Devices
  • Polysomnography Devices
  • Ambulatory PSG Devices
  • Clinical PSG Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers
  • Other Products

Diseases Covered:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other Diseases

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels

End Users Covered:

  • Hospitals
  • Homecare Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Respiratory Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Respiratory Consumables
    • 5.2.1 Respiratory Mask
    • 5.2.2 Nasal Cannulas
    • 5.2.3 Oxygen Tubing Sets
    • 5.2.4 Breathing Filters
  • 5.3 Nebulizers
    • 5.3.1 Compressed Jet Nebulizers
    • 5.3.2 Ultrasonic Nebulizers
    • 5.3.3 Other Nebulizers
  • 5.4 Oxygen Concentrators
    • 5.4.1 Home Oxygen Concentrators
    • 5.4.2 Portable Oxygen Concentrators
  • 5.5 Positive Airway Pressure (PAP) Devices
  • 5.6 Polysomnography Devices
  • 5.7 Ambulatory PSG Devices
  • 5.8 Clinical PSG Devices
  • 5.9 Pulse Oximeters
  • 5.10 Mechanical Ventilators
  • 5.11 Spirometers
  • 5.12 Other Products

6 Global Digital Respiratory Devices Market, By Disease

  • 6.1 Introduction
  • 6.2 Asthma
  • 6.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 6.4 Other Diseases

7 Global Digital Respiratory Devices Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Pharmacies
  • 7.5 Other Distribution Channels

8 Global Digital Respiratory Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Homecare Settings
  • 8.4 Other End Users

9 Global Digital Respiratory Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 3M Health Care Limited
  • 11.2 Adherium Limited
  • 11.3 AireHealth, Inc.
  • 11.4 Amiko Digital Health Limited
  • 11.5 Cognita Labs
  • 11.6 COHERO Health Inc.
  • 11.7 FindAir Sp. z o.o
  • 11.8 Novartis AG
  • 11.9 Pneuma Respiratory Inc.
  • 11.10 Propeller Health
  • 11.11 Teva Pharmaceuticals Industries Ltd.

List of Tables

  • Table 1 Global Digital Respiratory Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Digital Respiratory Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Digital Respiratory Devices Market Outlook, By Respiratory Consumables (2021-2030) ($MN)
  • Table 4 Global Digital Respiratory Devices Market Outlook, By Respiratory Mask (2021-2030) ($MN)
  • Table 5 Global Digital Respiratory Devices Market Outlook, By Nasal Cannulas (2021-2030) ($MN)
  • Table 6 Global Digital Respiratory Devices Market Outlook, By Oxygen Tubing Sets (2021-2030) ($MN)
  • Table 7 Global Digital Respiratory Devices Market Outlook, By Breathing Filters (2021-2030) ($MN)
  • Table 8 Global Digital Respiratory Devices Market Outlook, By Nebulizers (2021-2030) ($MN)
  • Table 9 Global Digital Respiratory Devices Market Outlook, By Compressed Jet Nebulizers (2021-2030) ($MN)
  • Table 10 Global Digital Respiratory Devices Market Outlook, By Ultrasonic Nebulizers (2021-2030) ($MN)
  • Table 11 Global Digital Respiratory Devices Market Outlook, By Other Nebulizers (2021-2030) ($MN)
  • Table 12 Global Digital Respiratory Devices Market Outlook, By Oxygen Concentrators (2021-2030) ($MN)
  • Table 13 Global Digital Respiratory Devices Market Outlook, By Home Oxygen Concentrators (2021-2030) ($MN)
  • Table 14 Global Digital Respiratory Devices Market Outlook, By Portable Oxygen Concentrators (2021-2030) ($MN)
  • Table 15 Global Digital Respiratory Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2021-2030) ($MN)
  • Table 16 Global Digital Respiratory Devices Market Outlook, By Polysomnography Devices (2021-2030) ($MN)
  • Table 17 Global Digital Respiratory Devices Market Outlook, By Ambulatory PSG Devices (2021-2030) ($MN)
  • Table 18 Global Digital Respiratory Devices Market Outlook, By Clinical PSG Devices (2021-2030) ($MN)
  • Table 19 Global Digital Respiratory Devices Market Outlook, By Pulse Oximeters (2021-2030) ($MN)
  • Table 20 Global Digital Respiratory Devices Market Outlook, By Mechanical Ventilators (2021-2030) ($MN)
  • Table 21 Global Digital Respiratory Devices Market Outlook, By Spirometers (2021-2030) ($MN)
  • Table 22 Global Digital Respiratory Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 23 Global Digital Respiratory Devices Market Outlook, By Disease (2021-2030) ($MN)
  • Table 24 Global Digital Respiratory Devices Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 25 Global Digital Respiratory Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 26 Global Digital Respiratory Devices Market Outlook, By Other Diseases (2021-2030) ($MN)
  • Table 27 Global Digital Respiratory Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 28 Global Digital Respiratory Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 29 Global Digital Respiratory Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 30 Global Digital Respiratory Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 31 Global Digital Respiratory Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 32 Global Digital Respiratory Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Global Digital Respiratory Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 34 Global Digital Respiratory Devices Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 35 Global Digital Respiratory Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.